A longterm follow-up study of thymidylate synthase as a predictor for survival of patients with liver tumours receiving hepatic arterial infusion chemotherapy
- 31 May 2004
- journal article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 30 (4) , 407-413
- https://doi.org/10.1016/j.ejso.2004.01.012
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Colorectal metastasis (liver and lung)Surgical Clinics of North America, 2002
- Conversion of locally inoperable primary rectal cancer with multiple liver metastases to an option for cure after local down-staging and hepatic arterial infusion chemotherapyLangenbecks Archives Of Surgery, 2002
- Hepatocellular carcinomaAnnals of Oncology, 2001
- Thymidylate synthase quantitation and in vitro chemosensitivity testing predicts responses and survival of patients with isolated nonresectable liver tumors receiving hepatic arterial infusion chemotherapyCancer, 2000
- Regional chemotherapy of non-resectable liver metastases from colorectal cancer - literature and institutional reviewLangenbecks Archives Of Surgery, 1999
- Thymidylate synthase is a predictor for response and resistance in hepatic artery infusion chemotherapyCancer Letters, 1997
- Resection of Nonresectable Liver Metastases from Colorectal Cancer After Neoadjuvant ChemotherapyAnnals of Surgery, 1996
- Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenaseEuropean Journal Of Cancer, 1994
- Biochemical determinants of 5-fluorouracil response in vivo. The role of deoxyuridylate pool expansion.Journal of Clinical Investigation, 1975